Clinical Trial Update: Testosterone and Growth Hormone for Bone Loss in Men [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating testosterone and growth hormone (somatropin) for bone loss in men with hypopituitarism or related hormone deficiencies; result…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Growth Hormone Deficiency
• Hypogonadism
• Hypopituitarism
• Osteoporosis

Drugs mentioned

• Somatropin (somatropin)
• TESTOSTERONE (testosterone)

Snippet

Sponsor: University of Pennsylvania | Conditions: Hypopituitarism, Hypogonadism | Phase 2 | Status: COMPLETED | Results posted: 2014-06-13